Basic outline for phase 2, slide ten. Thoughts? on study having two end points...
Randomized
“HER-Vaxx in combination with standard of care chemotherapy”
OR
“Standard of care chemo: Cisplatin and 5FU or capecitabine or oxaliplatin”
Would of thought the HER-Vaxx would be more beneficial for proof of concept and clinical validation. Which is the more beneficial of the two...?
Basic outline for phase 2, slide ten. Thoughts? on study having...
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.9¢ |
Change
0.001(2.63%) |
Mkt cap ! $386.7M | |||
| Open | High | Low | Value | Volume |
| 3.8¢ | 4.0¢ | 3.7¢ | $325.4K | 8.503M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 2394483 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 609265 | 6 |
View Market Depth
| Last trade - 11.58am 27/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
